Labcorp Completes Acquisition of Select Assets of Invitae to Extend Leadership in Genetic Testing Solutions
Labcorp Completes Acquisition of Select Assets of Invitae to Extend Leadership in Genetic Testing Solutions
08/05/24, 11:12 AM
Location
burlingtonsan franciscoIndustry
health care
biotechnology
Labcorp, a global leader in laboratory services, has finalized the acquisition of select assets of Invitae, a leading medical genetics company. This acquisition enhances Labcorp's specialty testing capabilities, allowing the company to utilize genetic data to improve clinical trials and treatment regimens in oncology and select rare diseases.
Company Info
Location
Burlington, North Carolina, United States
Company info
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With more than 70,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14.0 billion in FY2020. Learn about Labcorp at Labcorp.com, or follow us on LinkedIn and Twitter @Labcorp.